Seminars in Hematology
Volume 47, Issue 3 , Pages 266-273, July 2010

Use of Thrombopoietic Agents for the Thrombocytopenia of Liver Disease

  • Hans L. Tillmann

      Affiliations

    • Corresponding Author InformationCorresponding author: Hans L. Tillmann, MD, Assistant Professor of Medicine, Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715-7969
    • ,
  • John G. McHutchison

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Financial disclosures: H.L.T. has served as an adviser to Amgen concerning potential use of Nplate in liver disease. J.G.M. is an adviser and has received grant support from GSK in regard to their thrombopoeitic drug eltrombopag.

PII: S0037-1963(10)00059-4

doi:10.1053/j.seminhematol.2010.04.003

Seminars in Hematology
Volume 47, Issue 3 , Pages 266-273, July 2010

Article Tools

* Image Usage & Resolution